Cartesian Therapeutics
RNAC
#6732
Rank
C$0.65 B
Marketcap
$27.38
Share price
3.61%
Change (1 day)
-39.30%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.43

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.44. In 2021 the company made an earnings per share (EPS) of -$0.33 an increase over its 2020 EPS that were of -$0.95.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.43
2021-$0.33-65.22%
2020-$0.95-43.44%
2019-$1.69-58.08%
2018-$4.02-9.35%
2017-$4.44-29.16%
2016-$6.27